Literature DB >> 2829640

Effect of immunoglobulin G therapy on serum antibody titers to cytomegalovirus in burn patients.

K T Moran1, J N Thupari, T J O'Reilly, A M Munster.   

Abstract

We attempted to determine the incidence and significance of cytomegalovirus infection and the effect of immunoglobulin G infusions on specific cytomegalovirus titers in burn patients. On admission, 48 percent of a group of 120 patients (mean burn size 28.5 percent of the total body surface area) were seronegative, including 95 percent of all patients under 20 years of age. Subsequently, 4 of a subgroup of 26 patients (15 percent) had development of a primary infection, and 1 of these patients died from overwhelming bacterial infection. Immunoglobulin G infusion used in the prophylaxis of the septic complications achieved high titers of cytomegalovirus-specific immunoglobulin G, as well as the subsets immunoglobulin G1 and immunoglobulin G3 which are also active against cytomegalovirus.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2829640     DOI: 10.1016/s0002-9610(88)80718-9

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  4 in total

1.  Herpesviradae infections in severely burned children.

Authors:  Paul Wurzer; Megan R Cole; Robert P Clayton; Gabriel Hundeshagen; Omar Nunez Lopez; Janos Cambiaso-Daniel; Raimund Winter; Ludwik K Branski; Hal K Hawkins; Celeste C Finnerty; David N Herndon; Jong O Lee
Journal:  Burns       Date:  2017-04-15       Impact factor: 2.744

Review 2.  Acquisition of cytomegalovirus infection: an update.

Authors:  B A Forbes
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

Review 3.  Human herpes viruses in burn patients: A systematic review.

Authors:  Paul Wurzer; Ashley Guillory; Daryousch Parvizi; Robert P Clayton; Ludwik K Branski; Lars-P Kamolz; Celeste C Finnerty; David N Herndon; Jong O Lee
Journal:  Burns       Date:  2016-08-08       Impact factor: 2.744

Review 4.  Cytomegalovirus infection in critically ill patients: a systematic review.

Authors:  Ryosuke Osawa; Nina Singh
Journal:  Crit Care       Date:  2009-05-14       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.